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ABSTRACT  Analysis  by means of two-dimensional gel electrophoresis (IEF) of [nP]orthophos- 
phate-labeled  proteins  from  mitotic  and  interphase  transformed  amnion  cells  (AMA)  has 
shown that keratins IEF 31  (Mr =  50,000;  Hela protein catalogue  number), 36 (Mr -- 48,500), 
44 (Mr = 44,000), 46 (Mr = 43,500), as well as vimentin (IEF 26; Mr = 54,000) are phosphorylated 
above their interphase level  during mitosis.  Similar studies of normal human amnion epithelial 
cells  (AF type) confirmed the above observations except in the case of keratin  IEF 44 whose 
relative proportion was too low to be analyzed. 
Immunofluorescent  staining of methanol/acetone-treated  mitotic transformed amnion cells 
with  a  mouse  polyclonal  antibody  elicited  against  human  keratin  IEF  31  showed  a dotted 
staining  (with  a  fibrillar  background)  in  all  of  the  cells  in  late  anaphase/early  telophase 
(characteristic  "domino"  pattern) and  in a sizeable  proportion  of the cells  in other stages of 
mitosis.  Normal  mitotic  amnion  cells  on  the  other  hand  showed  a fine  fibrillar  staining  of 
keratins at all stages of mitosis.  Similar  immunofluorescent staining of normal and transformed 
mitotic cells with vimentin  antibodies  revealed a fibrillar distribution  of vimentin  in both cell 
types. 
Taken together the results indicate that the transformed amnion cells may contain a factor(s) 
that  modulates  the  organization  of  keratin  filaments  during  mitosis.  This  putative  factor(s), 
however, is most likely not a protein kinase as transformed amnion cells and amnion keratins 
are modified to similar extents.  It is suggested that in general  the preferential phosphorylation 
of  intermediate-sized  filament  proteins  during  mitosis  may  play  a  role  in  modulating  the 
various proposed associations  of these filaments with organelles  and other cellular structures. 
Epithelial cells contain intermediate-sized filaments (10 nm) 
composed of  proteins that are related to the epidermal keratins 
(for  a  recent  review  see  reference  1).  In  addition,  many 
cultured epithelial cells also express vimentin (2, 3). In mitotic 
HeLa  cells  these  proteins  are  phosphorylated  above  their 
interphase level (4-6) and we have suggested that these mod- 
ifications may be instrumental in assuring the process of cell 
division (4-6). A transient disintegration of keratin filaments 
throughout mitosis has been recently reported in several cul- 
tured epithelial cells (7-9), but this phenomenon is not general 
(9,  10). 
As yet there is no information as to whether there is any 
correlation between keratin aggregation and phosphorylation 
during mitosis (9). Towards this aim we present in this report 
a  comparative gel  electrophoresis and immunofluorescence 
study of the behavior of intermediate filament proteins during 
mitosis in normal and transformed human epithelial amnion 
cells.  The  results  indicate  that  transformed  amnion  cells 
(AMA) may contain a factor(s) that affects the dynamics of 
keratin organization during mitosis. This putative factor(s), 
however,  is most likely not a  protein  kinase  as AMA and 
amnion keratins are phosphorylated to a similar extent during 
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© The Rockefeller University Press  • 0021-9525/83/11/1429/06  $1.00  1429 FIGURE  1  Two-dimensional gel electrophoresis (IEF)  of [~5S]methionine-labeled  proteins from asynchronous AMA cells (P103; A) 
and human epithelial amnion cells (B; AF type) labeled for 16 h. IEF 31, 36, 44, 46, and k correspond to keratins, v, vimentin; at, 
a-tubulin; Bt, ~-tubulin. Some modified variants of the keratins and of vimentin are indicated in A (see also Table II and Fig. 2, A 
and B). 
mitosis. In general, the preferential phosphorylation of inter- 
mediate-sized filament proteins during mitosis is suggested to 
modulate filament organelle interactions. 
MATERIALS  AND  METHODS 
Cultured cells free of mycoplasm were grown routinely as monolayer cultures 
in Dulbecco'smodified  Eagle's minimal essential medium containing 10% fetal 
calf serum and antibiotics (100 u/ml penicillin,  50 #g/ml streptomycin).  The 
normal human amnion epithelial cells (from amnioncentesis, AF type [11, 12] 
passage 2) were kindly provided by the Department of  Human Genetics, Arhus 
University, Denmark. 
The preparation and characterization  of the mouse polyclonal  antibody 
against human keratin IEF 31  has been described in detail elsewhere (6). The 
vimentin antibody was a girl from Dr. S. Blose (Cold Spring Harbor Labora- 
tory). 
The procedures for preparing mitotic cells by mechanical detachment (4, 5, 
13), labeling with [3SS]methionine (14,  15) and [32P]orthophosphate (4), two- 
dimensional gel electrophoresis (4), and indirect immunofluorescence  of  meth- 
anol/acetone-fixed  cells (16) have been previously described. 
RESULTS 
Phosphorylation of Keratins  and Vimentin during 
Mitosis in Normal and Transformed Human 
Epithelial Amnion Cells 
Fig.  1 a shows the appropriate region of a two-dimensional 
gel fluorograph (IEF) ~  of [asS]methionine-labeled polypeptides 
from asynchronous human  AMA  labeled for 20  h  (6,  17). 
The positions of the four keratins present in these cells (IEF's 
31, Mr =  50,000;  36, Mr =  48,500; 44, Mr =  44,000, and 46, 
Mr =  43,500; HeLa protein catalogue number,  18-20, Table 
I) (6) as well as of vimentin (v), a- and ~-tubulin (at, Bt), and 
total actin  are  indicated  as  reference. At  least three  of the 
AMA keratins (IEF 31,  36,  and 46) as well as vimentin are 
present in normal cultured epithelial amnion cells (AF type; 
Fig.  1 b)  (6)  but  these  cells synthesized  lower amounts of 
keratins IEF 31 and 46 and higher amounts of vimentin (see 
Fig.  l, a and b; Table I) (6,  17). The keratin IEF 44 was either 
Abbreviations used in this paper:  IEF, isoelectric focusing. 
present in only very small amounts or was absent in amnion 
cells.  Cultured epithelial amnion cells contain in addition a 
low molecular weight keratin (Mr =  40,000;  k  in  Fig.  1 b, 
Table I) that was not detected in AMA cells (Fig.  1 a). This 
protein can be immunoprecipitated with a broad specificity 
keratin antibody but it has not been thoroughly characterized. 
In mitotic AMA cells the keratins as well as vimentin were 
phosphorylated above their interphase level (Fig.  2, a and b; 
21). The relevant fraction of IEF gels of [3ZP]orthophosphate- 
labeled proteins (15-min labeling) from mitotic and interphase 
AMA cells depleted of mitotic figures are shown in Fig.  2, a 
and  b,  respectively. For reference the positions of the  non- 
phosphorylated keratins and of vimentin are indicated in Fig. 
2  a  (mitotic  AMA  cells)  and  are  listed  in  Table  II.  The 
phosphorylated spots are indicated with their corresponding 
number in the HeLa protein catalogue (18-20). The authen- 
ticity of the modified proteins has been verified by immuno- 
precipitation using a broad specificity keratin antibody (21). 
The following modification products of IEF 31 (31c), 36 (33q, 
35b, 33p), 44  (44h,  44hl),  46  (46b), and  vimentin (26el, 
26e2) were preferentially detected during mitosis (Table II) 
although variable amounts of  some of  these polypeptides were 
also observed in interphase cells depleted of mitotic cells (Fig. 
2 b).  Since most of the  mitotic cells were in  prometaphase 
and metaphase (~65% of the cell population; not shown) it 
is likely that these modifications may take place in  or very 
near these phases of the cell cycle. Phosphoproteins IEF 31a, 
37, 44g, 46a, and 26e correspond to the  first modification 
products of the keratins and of vimentin (Fig.  2 a; Table II) 
and are the main phosphorylated form of these proteins in 
interphase  (Fig.  2  b)  (see  also  references 4,  5,  and  21).  A 
summary of the levels of modification of the various inter- 
mediate-sized filaments proteins in  interphase  as well as in 
mitosis is given in  Table I.  The data have been calculated 
from the analysis of [35S]methionine-labeled proteins. Clearly, 
the level of modification of keratins IEF 36 and 44 in inter- 
phase is significantly higher than that of  the two other keratins 
and  of vimentin  (see  Table  I).  In  all  cases,  however,  an 
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Intermediate-sized Filament Proteins of Normal and Transformed Human Amnion Cells 
AMA 
Intermediate-sized 
filament proteins  Mol wt  AMA/Amnion*  Interphase  Mitosis 
Amnion 
Interphase  Mitosis 
Kdalton  %*  %  %*  % 
Keratin 
IEF 31  50  2.50  18  38  17  ND  ~ 
IEF 36  48.5  1.36  34  57  27  50 
IEF 44  44  --~  27  54  ND  ND 
IEF 46  43.5  2.68  14  23  15  30 
IEF K  I  40  --~  ND  ND 
Vimentin 
IEF 26  54  0.21  13  33  9  29 
*Ratio based on the quantitation of [3SS]methione-labeled proteins. AF type amnion (1 I, 12). 
*% modification based on the quantitation of [35S]methione-labeled proteins. 
*In three preparations, the separation of IEF 31 from 31a was not optimal to allow quantitation. 
'This protein is not present in AMA cells. 
Barely detected or absent. 
FIGURE  2  Two-dimensional gel electrophoresis (IEF) of [32P]orthophosphate-labeled proteins (15-min labeling). (A) Mitotic AMA 
cells (P120); (B) asynchronous AMA cells depleted of mitotic cells; (C) normal mitotic amnion cells; and (D) asynchronous amnion 
cells depleted of mitotic cells.  In A  the position of the nonphosphorylated keratins and of vimentin are indicated as a reference. 
About 80% of the cells obtained by shake-off were in mitosis as determined by phase contrast microscopy. 
increased  modification  during  mitosis  has  been  observed 
(~50%; Table I). 
Similar gel analyses of [32p]orthophosphate-labeled proteins 
from normal mitotic amnion cells and of interphase amnion 
cells depleted of mitotic figures are shown in Fig. 2, c and d. 
Since the number of normal mitotic amnion cells that can be 
obtained by mechanical detachment is very small, the gel in 
Fig.  2  c  contains  much  fewer counts than  those  shown  in 
other panels of Fig. 2. In spite of this limitation it is possible 
to see that keratins IEF 31, 36, 46, and vimentin were phos- 
phorylated preferentially during mitosis. The above analysis 
further showed that the 40-kdalton keratin present in normal 
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Main Phosphorylated Products of Keratins and Vimentin in 
Transformed Human Epithelial Amnion Cells 
Intermediate-sized  Phosphorylated spots 
filament protein  (IEF)*  Predominant spots* 
Keratins 
IEF 31  31a  t, 31b  s, 31c  s  31c 
IEF 36  37, 33q, 35b, 33p  33q, 35b, 33p 
IEF 44  44g, 44h, 44hl s  44h, 44hl 
IEF 46  46a  t, 46b  t  46b 
Vimentin 
Vimentin I  26e, 26el s, 26e2  s  26el, 26e2 
*The authenticity of the modified variants has been assessed  by immunopre- 
cipitation (21). 
*Spots were observed in mitosis as compared with interphase cells. 
tThese numbers are new additions to the HeLa protein catalogue (18-20). 
IVimentin corresponds to IEF 26 in the HeLa protein catalogue (18-20). 
amnion  cells (k in  Fig.  1 b)  is  also  phosphorylated (short 
arrows  in  Fig.  2,  c  and  d).  A  summary of the  levels  of 
modification of the various intermediate-sized filament pro- 
teins is given in  Table I. Again, we found that the level of 
phosphorylation in  interphase was different for the various 
proteins (higher for IEF 36 and 44), but in all cases there was 
a  substantial increase in  mitosis (~50%;  Table I). This in- 
crease was similar to that observed in AMA cells. Only in the 
case of keratin  IEF 31  were we  not  able to quantitate  the 
extent of modification. 
Behavior of Keratin and Vimentin Filaments 
during Mitosis 
Mouse polyclonal antibodies raised against human keratin 
IEF 31  were used to determine the pattern of keratin distri- 
bution  during  mitosis  in  normal  and  human  AMA.  The 
antibody  reacted  mainly  with  protein  IEF  31,  although  it 
shows a  small  but  significant  cross-reactivity with  keratins 
IEF's 36, 44, and 46 (6). Immunofluorescence microscopy of 
AMA  at  various stages during  mitosis showed  a  granular, 
dotted staining in a  significant proportion of the cells at all 
stages of mitosis but not in early G1 (Fig.  3, b, f, j, n, and r; 
prophase is not shown).  In most cases,  however, a fine fila- 
mentous network was also detected but this was difficult to 
picture  as  it  lay  in  a  different  focal  plane  as  the  round 
fluorescent dots. We have encountered preparations, however, 
in which the dotted pattern was not observed (see also refer- 
ence 9), indicating as suggested by Lane et al. (9) that keratin 
reorganization is taking place close to its threshold limiting 
condition. Based on the observation of 20 preparations (show- 
ing the dotted  pattern), the following percentage of mitotic 
phases  showed  keratin  aggregation:  prophase,  20%  (not 
shown); metaphase, 40% (Fig. 3 b); anaphase, 80% (Fig. 3f); 
late anaphase/early telophase,  100% (Fig.  3 j), and late telo- 
phase, 46% (Fig. 3 n) (see also reference 9). Nearly all cells in 
early G1  showed a  fibrillar staining (Fig.  3  r) and  in  some 
spreading  cells  it  was  possible  to  see  short,  unconnected 
stained filaments similar to those described in Ptk2 by Aubin 
et al. (10) (not shown). Interestingly, only late anaphase/early 
telophase cells  consistently showed  a  dotted  pattern  in  all 
cases. The staining pattern was most striking as it resembled 
a domino (Fig. 3 j); the fluorescent dots were usually aligned 
in the central part between the two sets of chromosomes. The 
nature of the interaction involved in maintaining this struc- 
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ture  is  at  present  unknown.  The  domino  pattern  rapidly 
disappeared in late telophase as the dots first disorganized and 
later appeared to concentrate in the central part as well as in 
the  opposite end  of the  cells  (not  shown).  The  "domino" 
pattern has not been described before but Lane et al. (9) have 
shown that keratin aggregation reaches a peak in anaphase. 
The  above  results  contrasted  with  those  obtained  with 
vimentin antibodies which revealed a fibrillar distribution of 
vimentin in all stages of mitosis (Fig. 3, c, g, k, and o, prophase 
not shown) (10, 22). 
Similar studies of normal amnion cells  using the keratin 
IEF 31  antibody failed to reveal the dotted  pattern  at any 
stage during mitosis,  instead a  fine  fibrillar distribution  of 
keratins was observed (Fig.  3, d, h, l, and p; prophase is not 
shown). Essentially the same results were obtained with mouse 
polyclonal antibodies raised against human epidermal keratin 
k2 (23). In this case the dots showed a much stronger staining. 
Treatment of normal amnion cells with demecolcine for 3 h 
(10  ug/ml) did  not  result  in  the  appearance of the  dotted 
pattern as judged by immunofluorescence using the two ker- 
atin  antibodies (not  shown).  Incubation  of normal  mitotic 
amnion cells with vimentin antibodies also revealed a fibrillar 
staining throughout mitosis (results not shown). 
DISCUSSION 
Previous studies  by immunofluorescence and  electron  mi- 
croscopy have shown a breakdown of keratin filaments during 
mitosis in various immortal cell lines (7-9) exhibiting various 
degrees of transformation. This phenomenon is not general, 
however,  as  many cell  lines  show  intact  keratin  filaments 
throughout mitosis (9,  10). 
Our study of a pair of normal (limited lifespan) and trans- 
formed  human  epithelial  amnion  cells  indicated  that  the 
transformed cells  contain  a  factor(s) that  modulate keratin 
organization during mitosis. Since normal and transformed 
amnion cells show mainly quantitative differences in polypep- 
tide synthesis (17,  24),  it is likely that this putative factor is 
synthesized at  low  levels by the  amnion  cells and  that  its 
synthesis (or activity) is enhanced as a result of transforma- 
tion.  This  factor(s),  however,  is  most  likely  not  a  protein 
kinase as both AMA and normal amnion keratins are phos- 
phorylated to similar extents during mitosis. This result is in 
line with the observation that vimentin filaments remained 
intact during mitosis in both normal and transformed amnion 
cells despite the higher level of phosphorylation of vimentin 
during mitosis. The possibility must be considered, however, 
that keratin breakdown may be due to the phosphorylation 
of only certain keratins.  In the cell  pair we have used, only 
keratin  IEF  44  was  not  present  (or  present  in  very  low 
amounts) in amnion cells and therefore may be responsible 
for the  dotted  pattern  observed in  mitotic AMA  cells.  We 
consider this possibility unlikely, however, as human MCF-7 
cells (breast adenocarcinoma) that do not express IEF 44 (1) 
show keratin aggregation during mitosis (9).  From these re- 
sults it would seem that the preferential phosphorylation of 
intermediate-filament proteins observed during mitosis may 
serve a  more  subtle  function  (5,  see  also  reference  24  for 
further references). For example, phosphorylation may mod- 
ulate some of the proposed filament associations with organ- 
elles  or other cell  structures (16,  21,  25-35).  Recently,  we 
have presented  evidence indicating  that  in  AMA  cells the 
intermediate-sized filament proteins are coordinately modi- FIGURE 3  Immunofluorescent staining of normal and transformed  mitotic amnion cells using keratin and vimentin antibodies. 
Sparse-growing cultured cells were fixed with methanol/acetone and reacted with the antibodies as previously described  (14). 
Phase contrast of mitotic AMA cells (P125): (a) metaphase, (e) anaphase, (i) late anaphase/early telophase, (m) late telophase, and 
(q) early GI. Immunofluorescence: (b-d) metaphase, (f-h} anaphase, (j-i) late anaphase/early telophase, (n-p) late telophase, and 
(r-t)  early GI. (b, f, j,  n) Mitotic AMA cells reacted with the keratin  IEF 31  antibody. (c, g, k, o) as above but reacted with the 
vimentin antibody; (d, h,/, p) Normal mitotic amnion cells reacted with the keratin IEF 31 antibody, x  150. 
fled during mitosis and that the half-life of the phosphate is 
13 min for the keratins and 11 min for vimentin (21 ). These 
data are compatible with a regulatory role for phosphorylation 
during mitosis. There is increased evidence, however, from 
microinjection of intermediate-sized filament antibodies (31, 
36-38)  indicating that  a  collapse of these filaments has no 
obvious effect on  the  distribution  of organelles. We should 
emphasize, however, that  organelles (mitochondria,  for ex- 
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(see 16 and 35 for references) and that these interactions may 
not be equally susceptible to various treatments. 
It is unlikely that keratin degradation in a fashion similar 
to that described for vimentin (4, 5, 39, 40) may account for 
the drastic reorganization of keratins observed during mitosis 
in AMA cells.  This is mainly deduced from the analysis of 
[35S]methionine- and silver-stained gels that showed that the 
total amount of a given  keratin (unmodified plus modified 
products) in mitosis is similar to that of their interphase level. 
Interestingly,  however, one  of the mitotic specific  proteins 
described in HeLa cells (m9; [4, 5]) has recently been shown 
to have a mobility similar to that of a degradation product of 
either keratin IEF 31  or 36 as determined by immunoprecip- 
itation using a broad specificity keratin antibody (unpublished 
observations). Further studies will be necessary to determine 
whether specific degradation  of keratins takes place during 
mitosis. 
It  is  intriguing  why  some  keratin  filaments  need  to  be 
broken down (aggregated) during mitosis in transformed am- 
nion cells. Obviously, this reorganization is not essential for 
normal cell division and must reflect some anomaly devel- 
oped during transformation. Indeed, cultures of AMA cells 
showed an unusually high mitotic index that would not be 
expected from the duration of mitosis. At present we do not 
know at what stage during the transformation process filament 
fragmentation begins,  and further studies of early passaged 
transformed cells will be needed to answer this question. So 
far, properties such as immortality, tumorigenicity, anchorage 
independence, ploidy,  and duration of the mitotic cycle do 
not seem to correlate with keratin filament aggregation (9, 
and this article). 
Clearly,  the rearrangement of keratin filaments observed 
during mitosis in some transformed cells must play a role in 
the process of cell division; but clarification of this role will 
require a more refined analysis of mitosis. 
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